Drug Safety

Use of Screening Algorithms and Computer Systems to Efficiently Signal Higher-Than-Expected Combinations of Drugs and Events in the US FDA's Spontaneous Reports Database
pp. 381-392(12)
Authors: Szarfman A.; Machado S.G.; O'Neill R.T.

A Data Mining Approach for Signal Detection and Analysis
pp. 393-397(5)
Authors: Bate A.; Lindquist M.; Edwards I.R.; Orre R.

From Pharmacovigilance to Pharmacoperformance
pp. 399-405(7)
Author: Peachey J.

Good Pharmacovigilance Practices: Technology Enabled
pp. 407-414(8)
Authors: Nelson R.C.; Palsulich B.; Gogolak V.

Statistical Techniques for Signal Generation: The Australian Experience
pp. 415-421(7)
Authors: Purcell P.; Barty S.

Automated Signal Generation in Prescription-Event Monitoring
pp. 423-432(10)
Authors: Heeley E.; Wilton L.V.; Shakir S.A.W.

Signal Generation in the New Zealand Intensive Medicines Monitoring Programme: A Combined Clinical and Statistical Approach
pp. 433-439(7)
Author: Coulter D.M.

Prescription-Event Monitoring in Japan (J-PEM)
pp. 441-444(4)
Author: Kubota K.

Effects of Coding Dictionary on Signal Generation: A Consideration of Use of MedDRA Compared with WHO-ART
pp. 445-452(8)
Author: Brown E.G.

Use of Measures of Disproportionality in Pharmacovigilance: Three Dutch Examples
pp. 453-458(6)
Authors: Egberts A.C.G.; Meyboom R.H.B.; van Puijenbroek E.P.

Signal Selection and Follow-Up in Pharmacovigilance
pp. 459-465(7)
Authors: Meyboom R.H.B.; Lindquist M.; Egberts A.C.G.; Edwards I.R.

Causal Association in Pharmacovigilance and Pharmacoepidemiology: Thoughts on the Application of the Austin Bradford-Hill Criteria
pp. 467-471(5)
Authors: Shakir S.A.W.; Layton D.